期刊文献+

辛伐他汀和阿托伐他汀对冠心病患者的降血脂作用研究 被引量:26

Effect of simvastatin and atorvastatin on reducing blood lipid in patients with coronary heart disease
下载PDF
导出
摘要 目的评价辛伐他汀和阿托伐他汀对冠心病患者的降血脂作用。方法选取2013年1月~2014年1月于山东省聊城市第三人民医院收治的150例冠心病患者,采用随机法分为A、B 2组,每组75例。A组患者给予辛伐他汀治疗,B组患者给予阿托伐他汀治疗。比较2组患者治疗前后血脂变化情况。结果治疗后,A、B 2组患者临床症状得到缓解;TC、LDL-C指标均明显下降,与治疗前相比差异有统计学意义(P<0.05);但A、B 2组组间比较差异无统计学意义。结论辛伐他汀和阿托伐他汀均能有效改善患者血脂情况。 Objective To evaluete the effect of atorvastatin on reducing blood lipid in patients with coronary heart disease.Methods 150 cases of coronary heart disease patients collected in Liaocheng Third People’s Hospital of Shandong province from January 2013 to January 2014 were randomly divided into A,B two groups,each had is cases.Group A were treated with simvastatin,and group B were treated with atorvastatin.Blood lipid changes in two groups before and after treatment were compared. Results Compared with before treatment,the clinical sypotoms after treatment in two groups were allivate and TC,LDL-C indexes were significantly decreased (P <0.05 ).But there was no statistical significance between A and B groups. Conclusion Simvastatin and atorvastatin can effectively improve the blood lipid status in patients with coronary heart disease.
作者 孟昭斌
出处 《中国生化药物杂志》 CAS 北大核心 2014年第4期151-152,共2页 Chinese Journal of Biochemical Pharmaceutics
关键词 辛伐他汀 阿托伐他汀 冠心病 血脂水平 simvastatin atorvastatin coronary heart disease serum lipid levels
  • 相关文献

参考文献7

二级参考文献33

  • 1贾忠辉,刘志红,郑敬民,曾彩虹,黎磊石.大黄酸和辛伐他汀对db/db糖尿病小鼠脂代谢紊乱和肾脏保护作用的比较[J].肾脏病与透析肾移植杂志,2006,15(3):233-239. 被引量:29
  • 2Steven E. Nissen,Stephen J. Nicholls,Ilks Sipahi,Peter Libby,Joel S. Raichlen,Christie M. Ballantyne,Jean Davignon,Raimund Erbel,Jean Charles Fruchart,Jean-Claude Tardif,Paul Schoenhagen,Tim Crowe,Valerie Cain,Kathy Wolski,Marlene Coormastic,E. Murat Tuzcu,仝其广(译),王淑敏(译),胡大一(校).极高强度他汀治疗对冠状动脉粥样硬化消退的影响——ASTEROID试验[J].美国医学会杂志(中文版),2006,25(4):215-223. 被引量:344
  • 3Rosuvastatin Registration Clinical Trial Group.Cardiovascular Institute and Fu Wai Hospital,Peking Union Medical College and Chinese Academy of Medical Science,Beijing 100037,China.瑞舒伐他汀治疗中国高胆固醇血症患者疗效和安全性的随机双盲多中心对照研究[J].中华心血管病杂志,2007,35(3):207-211. 被引量:117
  • 4中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5219
  • 5Grundy SM, Cleeman JI, Merz, Brewer HB Jr, et al. National Heart, Lung, Blood Institute; American College of Cardiology Foundation;American Heart Association. Implications of recent clinical trials for National Cholesterol Education Progran Adult Treatment Panel Ⅲ guidelines[ J ]. Circulation, 2004,110 ( 2 ) : 227-239
  • 6LaRosa JC, Grundy SM,Waters DD, et al. Treating to New Targets(TNT) intensive lipid lowering with atorvastatin in patients with stable coronary disease[J]. N Engl J Med, 2005,36 : 288-295
  • 7Davidson M, Ma p, Stein EA, et al. Comparison ofeffectson low- density lipoprotein cholesterol and high -density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type Ⅱ a or hypercholesterlemia [ J ]. Am J Cardiol, 2002,89 ( 3 ) : 268-275
  • 8Olsson AG, Istad H, Luurila O, et al. On behalf of the Rosuvastatin Investihators Group. Effects of rosuvatatin and atorvastatin compared over 52 weeks of treatment in patients with hypereholesterolemia[J]. Am Heart J,2002,144 (6) :1 044-1 051
  • 9Brown WV, Bays HE, Hassman DR,et al. For the Rosuvastatin Study Group. Efficacy and safety of rosuvastatin compared with pravatatin and simvastatin in patients with hypercholesterolemia: a randomized, double, 52 - week trial [J]. Am Heart J,2002,144(6) :1 036-1 043
  • 10Paoletti R, Fahmy M, Mahla G, et al. Rosuvastatin demonstrates greater education of low - density lipoprotein cholesterol compared with pravatatin and simvastatin in hypercholesterolemia patients: a randomized, double - blind study [ J ]. J Carsiovasc Risk, 2001,8 ( 6 ) : 383-390

共引文献115

同被引文献197

引证文献26

二级引证文献315

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部